Deriving meaningful insights from clinical trial and postmarketing safety data: Perspectives from India

Deriving meaningful insights from clinical trial and postmarketing safety data: Perspectives from India

Today, drug safety data collection in India is both manual and electronic with reporting of potential overlapping and duplicate data, which is likely incomplete for further review and analysis. Furthermore, standardized data collection and timelines are not aligned with international standards. Comp...

Full description

Bibliographic Details
Main Authors: Anand Harugeri, Vineet Shastri, Chanakya Patel
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Perspectives in Clinical Research
Subjects:
Adverse drug reaction
clinical trial
drug safety
India
pharmacovigilance
Online Access:http://www.picronline.org/article.asp?issn=2229-3485;year=2017;volume=8;issue=2;spage=68;epage=72;aulast=Harugeri

Similar Items

Similar Items